Global Anticoagulants Market Report 2024

Anticoagulants Global Market Report 2024 – By Drug Class (Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes), By Route Of Administration (Oral Anticoagulant, Injectable Anticoagulant), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications), By End User (Hospitals, Homecare, Specialty Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Anticoagulants Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Anticoagulants Market Definition And Segments

Anticoagulants refer to a drug used to prevent and treat blood clots in the heart and blood arteries. called a blood thinner as well. It is utilized to slow down the body's clotting process. These are blood thinners, but they do not thin the blood, instead, they avoid or minimize clots or thrombi.

The main drug classes of anticoagulants are Factor Xa Inhibitor, Heparin & LMWH, Vitamin K Antagonist, and others. Factor Xa inhibitors are anticoagulants that inhibit clot formation by specifically and reversibly blocking the function of clotting factor Xa. The different routes of administration include oral anticoagulants, and injectable anticoagulants and are distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacy. It is used in venous thromboembolism, atrial fibrillation or flutter, coronary artery disease, and others and is used in hospitals, home care, specialty centers, and others.

The anticoagulants market covered in this report is segmented –

1) By Drug Class: Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes

2) By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

4) By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications

5) By End User: Hospitals, Homecare, Specialty Centers, Other End-Users

The anticoagulants market size has grown rapidly in recent years. It will grow from $45.18 billion in 2023 to $49.89 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to aging population, increased prevalence of cardiovascular diseases, rising awareness about the importance of anticoagulant therapy, expansion of indications for anticoagulant use, increased incidence of venous thromboembolism (VTE) and atrial fibrillation.

The anticoagulants market size is expected to see rapid growth in the next few years. It will grow to $77.71 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to expansion of indications for novel anticoagulant drugs, rising healthcare expenditure, emergence of novel oral anticoagulants (NOACs) as primary treatment options, financial support offered by central authorities to revamp healthcare facilities, expansion of the healthcare infrastructure. Major trends in the forecast period include advancements in medical technologies and diagnostic methods, integration of artificial intelligence and data analytics in anticoagulant therapy, growing emphasis on patient education and adherence programs, development of reversal agents.

Cardiovascular Diseases Fueling Growth In The Anticoagulants Market

The increasing cardiovascular diseases are a key factor driving the growth of the anticoagulants market over the coming years. CVDs (cardiovascular diseases) are a category of heart and blood vessel problems. Cardiovascular diseases (CVDs) are the primary, source of death worldwide with low- and middle-income nations accounting for three-quarters of CVD deaths. Anticoagulation pharmacotherapy known as direct oral anticoagulants is used to minimize thrombosis in a variety of cardiovascular situations. According to the World Health Organization report in 2021, cardiovascular diseases claimed the lives of 17.9 million individuals worldwide, accounting for 32% of all deaths. Heart attacks and strokes were responsible for 85% of these deaths. Therefore, the increasing cardiovascular diseases drive the growth of the anticoagulants market.

Growing Number Of Hospitals Fuels Anticoagulants Market Expansion

The increasing number of hospitals is expected to propel the growth of the anticoagulants market going forward. Hospitals are healthcare facilities that provide medical treatment, care, and support to individuals who are suffering from various illnesses, injuries, or medical conditions. Anticoagulants are used in hospitals for the prevention of blood clots, treatment of thromboembolic disorders, management of heart conditions, preventing recurrent strokes, and reduced risk of postoperative complications. For instance, in August 2023, according to Interweave Textiles Limited, a UK-based company that specializes in the manufacturing of textiles and related products, there are 1148 hospitals in the UK. Therefore, the increasing number of hospitals is driving the growth of the anticoagulants market.

Major companies operating in the anticoagulants market report are GlaxoSmithKline plc, Leo Pharma A/S, Alexion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Mylan N. V., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi S. A., Apotex Inc., Aspen Pharmacare Holdings Limited, AstraZeneca plc, Bristol-Myers Squibb Company, CSL Behring, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Fresenius Kabi AG, Hikma Pharmaceuticals plc, Johnson & Johnson, Lupin Limited, Mitsubishi Tanabe Pharma Corporation, Natco Pharma Limited, Novartis International AG, Portola Pharmaceuticals Inc., Strides Pharma Science Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, Torrent Pharmaceuticals Limited, Zydus Cadila Healthcare Limited

Anticoagulant Clinical Trials In Response To COVID-19 Is Shaping The Anticoagulants Market

The ongoing clinical trials of anticoagulant treatments for COVID-19 are shaping the anticoagulants market. Major companies operating in the anticoagulants sector are concentrating on establishing clinical trials of anticoagulant medications to lower the risk of COVID-19-related blood clotting in adults. For instance, in March 2021, The National Institutes of Health (NIH) in the USA started the final of three Phase III clinical trials of blood thinners (anticoagulants) to prohibit life-threatening blood clots in elderly people with COVID-19.The ACTIV-4 trials will help to resolve concerns about the use of anticoagulants also known as antithrombotics in the treatment of COVID-19.

Increasing Focus On Product Innovations To Provide Reliable Services To Their Customers

Major companies operating in the anticoagulants market are focusing on innovative products such as sodium citrate 4% anticoagulant solution to drive revenues in their market. Sodium citrate 4% anticoagulant solution is a medical solution that contains 4% sodium citrate in a liquid form which is used to prevent the clotting of blood. For instance, in August 2023, Fresenius Kabi AG, a Germany-based healthcare group specializing in pharmaceuticals and medical devices, launched sodium citrate 4% anticoagulant solution. When used in conjunction with apheresis equipment, sodium citrate is an essential product for the collection and storage of blood and blood components. The 250 mL container of sodium citrate 4% anticoagulant solution is made to comply with Canada's most stringent requirements for plasma donation. Sodium citrate, by binding calcium ions, prevents the coagulation cascade, allowing blood to remain in a liquid state for diagnostic testing and other medical purposes.

Pharmaniaga Berhad's Collaboration With Suzhou Ronnsi Pharma To Develop Halal Anticoagulant Products

In August 2022, Pharmaniaga Berhad, a Malaysia-based pharmaceutical company, partnered with Suzhou Ronnsi Pharma Co. Ltd. This partnership attempts to address the growing need for non-communicable illness therapies in tandem with the aging population, which is driving up demand for halal medications. The partnership will facilitate commerce in pharmaceutical items, research and development, and eventually fill and complete the halal ovine anticoagulant product. Suzhou Ronnsi Pharma Co. Ltd is a China-based company that manufactures anticoagulants.

North America was the largest region in the anticoagulants market in 2023. The regions covered in the anticoagulants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the anticoagulants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The anticoagulants market consists of sales of rivaroxaban, dabigatran, apixaban, and edoxaban. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The anticoagulants market research report is one of a series of new reports from The Business Research Company that provides anticoagulants market statistics, including anticoagulants industry global market size, regional shares, competitors with an anticoagulants market share, detailed anticoagulants market segments, market trends and opportunities, and any further data you may need to thrive in the anticoagulants industry. This anticoagulants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Anticoagulants Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $49.89 billion
Revenue Forecast In 2033 $77.71 billion
Growth Rate CAGR of 11.7% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Drug Class: Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes
2) By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications
5) By End User: Hospitals, Homecare, Specialty Centers, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled GlaxoSmithKline plc; Leo Pharma A/S; Alexion Pharmaceuticals Inc.; Amphastar Pharmaceuticals Inc.; Bayer AG; Boehringer Ingelheim International GmbH; Daiichi Sankyo Company Limited; Eisai Co. Ltd.; Mylan N. V.; Otsuka Holdings Co. Ltd.; Pfizer Inc.; Sanofi S. A.; Apotex Inc.; Aspen Pharmacare Holdings Limited; AstraZeneca plc; Bristol-Myers Squibb Company; CSL Behring; Dr. Reddy's Laboratories Ltd.; Eli Lilly and Company; Fresenius Kabi AG; Hikma Pharmaceuticals plc; Johnson & Johnson; Lupin Limited; Mitsubishi Tanabe Pharma Corporation; Natco Pharma Limited; Novartis International AG; Portola Pharmaceuticals Inc.; Strides Pharma Science Limited; Sun Pharmaceutical Industries Limited; Teva Pharmaceutical Industries Limited; Torrent Pharmaceuticals Limited; Zydus Cadila Healthcare Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Anticoagulants Market Characteristics

    3. Anticoagulants Market Trends And Strategies

    4. Anticoagulants Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Anticoagulants Market Size and Growth

    5.1. Global Anticoagulants Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Anticoagulants Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Anticoagulants Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Anticoagulants Market Segmentation

    6.1. Global Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Factor Xa Inhibitor

    Heparin And LMWH

    Vitamin K Antagonist

    Other Drug Classes

    6.2. Global Anticoagulants Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral Anticoagulant

    Injectable Anticoagulant

    6.3. Global Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Venous Thromboembolism

    Atrial Fibrillation Or Flutter

    Coronary Artery Disease

    Other Applications

    6.4. Global Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Homecare

    Specialty Centers

    Other End-Users

    7. Anticoagulants Market Regional And Country Analysis

    7.1. Global Anticoagulants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Anticoagulants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Anticoagulants Market

    8.1. Asia-Pacific Anticoagulants Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Anticoagulants Market

    9.1. China Anticoagulants Market Overview

    9.2. China Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Anticoagulants Market

    10.1. India Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Anticoagulants Market

    11.1. Japan Anticoagulants Market Overview

    11.2. Japan Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Anticoagulants Market

    12.1. Australia Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Anticoagulants Market

    13.1. Indonesia Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Anticoagulants Market

    14.1. South Korea Anticoagulants Market Overview

    14.2. South Korea Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Anticoagulants Market

    15.1. Western Europe Anticoagulants Market Overview

    15.2. Western Europe Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Anticoagulants Market

    16.1. UK Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Anticoagulants Market

    17.1. Germany Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Anticoagulants Market

    18.5. France Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Anticoagulants Market

    19.9. Italy Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Anticoagulants Market

    20.13. Spain Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Anticoagulants Market

    21.1. Eastern Europe Anticoagulants Market Overview

    21.2. Eastern Europe Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Anticoagulants Market

    22.1. Russia Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Anticoagulants Market

    23.1. North America Anticoagulants Market Overview

    23.2. North America Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Anticoagulants Market

    24.1. USA Anticoagulants Market Overview

    24.2. USA Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Anticoagulants Market

    25.1. Canada Anticoagulants Market Overview

    25.2. Canada Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Anticoagulants Market

    26.1. South America Anticoagulants Market Overview

    26.2. South America Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Anticoagulants Market

    27.1. Brazil Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Anticoagulants Market

    28.1. Middle East Anticoagulants Market Overview

    28.2. Middle East Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Anticoagulants Market

    29.1. Africa Anticoagulants Market Overview

    29.2. Africa Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Anticoagulants Market Competitive Landscape And Company Profiles

    30.1. Anticoagulants Market Competitive Landscape

    30.2. Anticoagulants Market Company Profiles

    30.2.1. GlaxoSmithKline plc

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Leo Pharma A/S

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Alexion Pharmaceuticals Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Amphastar Pharmaceuticals Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Bayer AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Anticoagulants Market Competitive Benchmarking

    32. Global Anticoagulants Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Anticoagulants Market

    34. Anticoagulants Market Future Outlook and Potential Analysis

    34.1 Anticoagulants Market In 2028 - Countries Offering Most New Opportunities

    34.2 Anticoagulants Market In 2028 - Segments Offering Most New Opportunities

    34.3 Anticoagulants Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Anticoagulants Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Anticoagulants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Anticoagulants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: GlaxoSmithKline plc Financial Performance
  • Table 76: Leo Pharma A/S Financial Performance
  • Table 77: Alexion Pharmaceuticals Inc. Financial Performance
  • Table 78: Amphastar Pharmaceuticals Inc. Financial Performance
  • Table 79: Bayer AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Anticoagulants Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Anticoagulants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Anticoagulants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Anticoagulants Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: GlaxoSmithKline plc Financial Performance
  • Figure 76: Leo Pharma A/S Financial Performance
  • Figure 77: Alexion Pharmaceuticals Inc. Financial Performance
  • Figure 78: Amphastar Pharmaceuticals Inc. Financial Performance
  • Figure 79: Bayer AG Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Blood And Blood Components Global Market Report 2024 – By Product (Whole Blood, Blood Components), By Blood Components (Red Blood Cells, Platelets, Plasma, White Blood Cells), By End-User (Hospitals, Ambulatory Surgical Centers, Others), By Application (Anemia, Trauma and Surgery, Cancer Treatment, Bleeding Disorders) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Blood Group Typing Global Market Report 2024 – By Test Type (Antibody Screening, Cross-Matching Tests, ABO Tests, Antigen Typing, HLA Typing), By Product (Instruments, Reagents And Kits), By Techniques (Serology Tests, Molecular Tests), By End User (Hospital Based Laboratories, Independent Laboratories And Blood Banks) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Blood Glucose Meters Global Market Report 2024 – By Product type (Electrode Type Blood Glucose Meter, Photoelectric Blood Glucose Meter), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Hospitals, Home Care) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Blood Cancer Drugs Global Market Report 2024 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Other Drugs), By Treatment Approaches (Key Findings, Chemotherapeutic, mAbs/Targeted Therapies, Immunotherapeutic) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Blood Transfusion Diagnostics Global Market Report 2024 – By Type (Instruments and Kits, Reagents, Other Types), By Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test), By Application (Blood Grouping, Disease Screening), By End User (Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Blood Collection Devices Global Market Report 2024 – By Type (Blood Collection Tubes, Lancet, Micro Container Tubes, Warming Devices), By Method (Manual Blood Collection, Automatic Blood Collection), By Material (Glass, Stainless Steel, Plastic), By End User (Hospitals, Blood Donation Centers, Diagnostic Center, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Dialysis Devices And Equipment Global Market Report 2024 – By Product (Hemodialysis Devices, Peritoneal Dialysis Devices, Continuous Renal Replacement Therapy (CRRT) Systems, Consumables), By Application (Serum And Blood Treatment, Virus Purification, Drug Binding Studies), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Hemodialysis And Peritoneal Dialysis Global Market Report 2024 – By Type (Hemodialysis, Short-Term Catheter, Chronic Catheter, Graft, Fistula, Peritoneal Dialysis), By Modality (Conventional, Daily (Day Time, Night Time)), By End User (Hospitals, Clinics, And Dialysis Centers, Home Dialysis) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the anticoagulants market?

Anticoagulants refer to a drug used to prevent and treat blood clots in the heart and blood arteries. called a blood thinner as well. It is utilized to slow down the body's clotting process. These are blood thinners, but they do not thin the blood, instead, they avoid or minimize clots or thrombi. For further insights on the anti-jamming market, request a sample here

How will the anticoagulants market drivers and restraints affect the anticoagulants market dynamics? What forces will shape the anticoagulants industry going forward?

The anticoagulants market major growth driver - cardiovascular diseases fueling growth in the anticoagulants market. For further insights on the anti-jamming market, request a sample here

What is the forecast market size or the forecast market value of the anticoagulants market ?

The anticoagulants market size has grown rapidly in recent years. It will grow from $45.18 billion in 2023 to $49.89 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to aging population, increased prevalence of cardiovascular diseases, rising awareness about the importance of anticoagulant therapy, expansion of indications for anticoagulant use, increased incidence of venous thromboembolism (vte) and atrial fibrillation.. The anticoagulants market size is expected to see rapid growth in the next few years. It will grow to $77.71 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to expansion of indications for novel anticoagulant drugs, rising healthcare expenditure, emergence of novel oral anticoagulants (noacs) as primary treatment options, financial support offered by central authorities to revamp healthcare facilities, expansion of the healthcare infrastructure. Major trends in the forecast period include advancements in medical technologies and diagnostic methods, integration of artificial intelligence and data analytics in anticoagulant therapy, growing emphasis on patient education and adherence programs, development of reversal agents. For further insights on the anti-jamming market, request a sample here

How is the anticoagulants market segmented?

The anticoagulants market is segmentedThe anticoagulants market covered in this report is segmented –
1) By Drug Class: Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes
2) By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications
5) By End User: Hospitals, Homecare, Specialty Centers, Other End-UsersFor further insights on the anti-jamming market, request a sample here

Which region has the largest share of the anticoagulants market? What are the other regions covered in the report?

North America was the largest region in the anticoagulants market in 2023. The regions covered in the anticoagulants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the anti-jamming market, request a sample here.

Who are the major players in the anticoagulants market?

Major companies operating in the anticoagulants market report are GlaxoSmithKline plc, Leo Pharma A/S, Alexion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Mylan N. V., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi S. A., Apotex Inc., Aspen Pharmacare Holdings Limited, AstraZeneca plc, Bristol-Myers Squibb Company, CSL Behring, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Fresenius Kabi AG, Hikma Pharmaceuticals plc, Johnson & Johnson, Lupin Limited, Mitsubishi Tanabe Pharma Corporation, Natco Pharma Limited, Novartis International AG, Portola Pharmaceuticals Inc., Strides Pharma Science Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, Torrent Pharmaceuticals Limited, Zydus Cadila Healthcare Limited For further insights on the anti-jamming market, request a sample here.

What are the key trends in the anticoagulants market?

Major trend in the anticoagulants market - anticoagulant clinical trials in response to covid-19 is shaping the anticoagulants market. For further insights on the anti-jamming market, request a sample here.

What are the major opportunities in the anticoagulants market? What are the strategies for the anticoagulants market?

For detailed insights on the major opportunities and strategies in the anticoagulants market, request a sample here.

How does the anticoagulants market relate to the overall economy and other similar markets?

For detailed insights on anticoagulants market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the anticoagulants industry?

For detailed insights on the mergers and acquisitions in the anticoagulants industry, request a sample here.

What are the key dynamics influencing the anticoagulants market growth? SWOT analysis of the anticoagulants market.

For detailed insights on the key dynamics influencing the anticoagulants market growth and SWOT analysis of the anticoagulants industry, request a sample here.